Microdialysis

Last updated
Microdialysis probes manufactured by CMA Microdialysis AB, Kista, Sweden CMA Microdialysis probes.jpg
Microdialysis probes manufactured by CMA Microdialysis AB, Kista, Sweden

Microdialysis is a minimally-invasive sampling technique that is used for continuous measurement of free, unbound analyte concentrations in the extracellular fluid of virtually any tissue. Analytes may include endogenous molecules (e.g. neurotransmitter, hormones, glucose, etc.) to assess their biochemical functions in the body, or exogenous compounds (e.g. pharmaceuticals) to determine their distribution within the body. The microdialysis technique requires the insertion of a small microdialysis catheter (also referred to as microdialysis probe) into the tissue of interest. The microdialysis probe is designed to mimic a blood capillary and consists of a shaft with a semipermeable hollow fiber membrane at its tip, which is connected to inlet and outlet tubing. The probe is continuously perfused with an aqueous solution (perfusate) that closely resembles the (ionic) composition of the surrounding tissue fluid at a low flow rate of approximately 0.1-5μL/min. [1] Once inserted into the tissue or (body)fluid of interest, small solutes can cross the semipermeable membrane by passive diffusion. The direction of the analyte flow is determined by the respective concentration gradient and allows the usage of microdialysis probes as sampling as well as delivery tools. [1] The solution leaving the probe (dialysate) is collected at certain time intervals for analysis.

Contents

History

The microdialysis principle was first employed in the early 1960s, when Push–pull perfusion [2] and dialysis sacs [3] were implanted into animal tissues, especially into rodent brains, to directly study the tissues' biochemistry. [1] While these techniques had a number of experimental drawbacks, such as the number of samples per animal or no/limited time resolution, the invention of continuously perfused dialytrodes in 1972 helped to overcome some of these limitations. [4] Further improvement of the dialytrode concept resulted in the invention of the "hollow fiber", a tubular semipermeable membrane with a diameter of ~200-300μm, in 1974. [5] Today's most prevalent shape, the needle probe, consists of a shaft with a hollow fiber at its tip and can be inserted by means of a guide cannula into the brain and other tissues. An alternative method, open flow micro-perfusion (OFM), replaces the membrane with macroscopic openings which facilitates sampling of lipophilic [6] [7] [8] and hydrophilic compounds, [9] protein bound and unbound drugs, [10] [11] neurotransmitters, peptides and proteins, antibodies, [12] [13] [14] nanoparticles and nanocarriers, enzymes and vesicles.

Microdialysis probes

Schematic illustration of a microdialysis probe Schematic illustration of a microdialysis probe.png
Schematic illustration of a microdialysis probe

There are a variety of probes with different membrane and shaft length combinations available. The molecular weight cutoff of commercially available microdialysis probes covers a wide range of approximately 6-100kD, but also 1MD is available. While water-soluble compounds generally diffuse freely across the microdialysis membrane, the situation is not as clear for highly lipophilic analytes, where both successful (e.g. corticosteroids) and unsuccessful microdialysis experiments (e.g. estradiol, fusidic acid) have been reported. [15] However, the recovery of water-soluble compounds usually decreases rapidly if the molecular weight of the analyte exceeds 25% of the membrane’s molecular weight cutoff.

Recovery and calibration methods

Due to the constant perfusion of the microdialysis probe with fresh perfusate, a total equilibrium cannot be established. [1] This results in dialysate concentrations that are lower than those measured at the distant sampling site. In order to correlate concentrations measured in the dialysate with those present at the distant sampling site, a calibration factor (recovery) is needed. [16] The recovery can be determined at steady-state using the constant rate of analyte exchange across the microdialysis membrane. The rate at which an analyte is exchanged across the semipermeable membrane is generally expressed as the analyte’s extraction efficiency. The extraction efficiency is defined as the ratio between the loss/gain of analyte during its passage through the probe (Cin−Cout) and the difference in concentration between perfusate and distant sampling site (Cin−Csample).

In theory, the extraction efficiency of a microdialysis probe can be determined by: 1) changing the drug concentrations while keeping the flow rate constant or 2) changing the flow rate while keeping the respective drug concentrations constant. At steady-state, the same extraction efficiency value is obtained, no matter if the analyte is enriched or depleted in the perfusate. [1] Microdialysis probes can consequently be calibrated by either measuring the loss of analyte using drug-containing perfusate or the gain of analyte using drug-containing sample solutions. To date, the most frequently used calibration methods are the low-flow-rate method, the no-net-flux method, [17] the dynamic (extended) no-net-flux method, [18] and the retrodialysis method. [19] The proper selection of an appropriate calibration method is critically important for the success of a microdialysis experiment. Supportive in vitro experiments prior to the use in animals or humans are therefore recommended. [1] In addition, the recovery determined in vitro may differ from the recovery in humans. Its actual value therefore needs to be determined in every in vivo experiment. [15]

Low-flow-rate method

The low-flow-rate method is based on the fact that the extraction efficiency is dependent on the flow-rate. At high flow-rates, the amount of drug diffusing from the sampling site into the dialysate per unit time is smaller (low extraction efficiency) than at lower flow-rates (high extraction efficiency). At a flow-rate of zero, a total equilibrium between these two sites is established (Cout = Csample). This concept is applied for the (low-)flow-rate method, where the probe is perfused with blank perfusate at different flow-rates. Concentration at the sampling site can be determined by plotting the extraction ratios against the corresponding flow-rates and extrapolating to zero-flow. The low-flow-rate method is limited by the fact that calibration times may be rather long before a sufficient sample volume has been collected.[ citation needed ]

No-net-flux-method

During calibration with the no-net-flux-method, the microdialysis probe is perfused with at least four different concentrations of the analyte of interest (Cin) and steady-state concentrations of the analyte leaving the probe are measured in the dialysate (Cout). [17] The recovery for this method can be determined by plotting Cout−Cin over Cin and computing the slope of the regression line. If analyte concentrations in the perfusate are equal to concentrations at the sampling site, no-net flux occurs. Respective concentrations at the no-net-flux point are represented by the x-intercept of the regression line. The strength of this method is that, at steady-state, no assumptions about the behaviour of the compound in the vicinity of the probe have to be made, since equilibrium exists at a specific time and place. [15] However, under transient conditions (e.g. after drug challenge), the probe recovery may be altered resulting in biased estimates of the concentrations at the sampling site. To overcome this limitation, several approaches have been developed that are also applicable under non-steady-state conditions. One of these approaches is the dynamic no-net-flux method. [18]

Dynamic no-net-flux method

While a single subject/animal is perfused with multiple concentrations during the no-net-flux method, multiple subjects are perfused with a single concentration during the dynamic no-net-flux (DNNF) method. [18] Data from the different subjects/animals is then combined at each time point for regression analysis allowing determination of the recovery over time. The design of the DNNF calibration method has proven very useful for studies that evaluate the response of endogenous compounds, such as neurotransmitters, to drug challenge. [18]

Retrodialysis

During retrodialysis, the microdialysis probe is perfused with an analyte-containing solution and the disappearance of drug from the probe is monitored. The recovery for this method can be computed as the ratio of drug lost during passage (Cin−Cout) and drug entering the microdialysis probe (Cin). In principle, retrodialysis can be performed using either the analyte itself (retrodialysis by drug) or a reference compound (retrodialysis by calibrator) that closely resembles both the physiochemical and the biological properties of the analyte. [19] Despite the fact that retrodialysis by drug cannot be used for endogenous compounds as it requires absence of analyte from the sampling site, this calibration method is most commonly used for exogenous compounds in clinical settings. [1]

Applications

The microdialysis technique has undergone much development since its first use in 1972, [4] when it was first employed to monitor concentrations of endogenous biomolecules in the brain. [20] Today's area of application has expanded to monitoring free concentrations of endogenous as well as exogenous compounds in virtually any tissue. Although microdialysis is still primarily used in preclinical animal studies (e.g. laboratory rodents, dogs, sheep, pigs), it is now increasingly employed in humans to monitor free, unbound drug tissue concentrations as well as interstitial concentrations of regulatory cytokines and metabolites in response to homeostatic perturbations such as feeding and/or exercise. [21]

When employed in brain research, microdialysis is commonly used to measure neurotransmitters (e.g. dopamine, serotonin, norepinephrine, acetylcholine, [22] glutamate, GABA) and their metabolites, as well as small neuromodulators (e.g. cAMP, cGMP, NO), amino acids (e.g. glycine, cysteine, tyrosine), and energy substrates (e.g. glucose, lactate, pyruvate). Exogenous drugs to be analyzed by microdialysis include new antidepressants, antipsychotics, as well as antibiotics and many other drugs that have their pharmacological effect site in the brain. The first non-metabolite to be analyzed by microdialysis in vivo in the human brain was rifampicin. [23] [24] [25]

Applications in other organs include the skin (assessment of bioavailability and bioequivalence of topically applied dermatological drug products), [26] and monitoring of glucose concentrations in patients with diabetes (intravascular or subcutaneous probe placement). The latter may even be incorporated into an artificial pancreas system for automated insulin administration.

Microdialysis has also found increasing application in environmental research, [27] sampling a diversity of compounds from waste-water and soil solution, including saccharides, [28] metal ions, [29] micronutrients, [30] organic acids, [31] and low molecular weight nitrogen. [32] Given the destructive nature of conventional soil sampling methods, [33] microdialysis has potential to estimate fluxes of soil ions that better reflect an undisturbed soil environment.

Critical analysis

Advantages

  1. To date, microdialysis is the only in vivo sampling technique that can continuously monitor drug or metabolite concentrations in the extracellular fluid of virtually any tissue. Depending on the exact application, analyte concentrations can be monitored over several hours, days, or even weeks. Free, unbound extracellular tissue concentrations are in many cases of particular interest as they resemble pharmacologically active concentrations at or close to the site of action. Combination of microdialysis with modern imaging techniques, such positron emission tomography, further allow for determination of intracellular concentrations.
  2. Insertion of the probe in a precise location of the selected tissue further allows for evaluation of extracellular concentration gradients due to transporter activity or other factors, such as perfusion differences. It has, therefore, been suggested as the most appropriate technique to be used for tissue distribution studies.
  3. Exchange of analyte across the semipermeable membrane and constant replacement of the sampling fluid with fresh perfusate prevents drainage of fluid from the sampling site, which allows sampling without fluid loss. Microdialysis can consequently be used without disturbing the tissue conditions by local fluid loss or pressure artifacts, which can occur when using other techniques, such as microinjection or push-pull perfusion.
  4. The semipermeable membrane prevents cells, cellular debris, and proteins from entering into the dialysate. Due to the lack of protein in the dialysate, a sample clean-up prior to analysis is not needed and enzymatic degradation is not a concern.

Limitations

  1. Despite scientific advances in making microdialysis probes smaller and more efficient, the invasive nature of this technique still poses some practical and ethical limitations. For example, it has been shown that implantation of a microdialysis probe can alter tissue morphology resulting in disturbed microcirculation, rate of metabolism or integrity of physiological barriers, such as the blood–brain barrier. [34] While acute reactions to probe insertion, such as implantation traumas, require sufficient recovery time, additional factors, such as necrosis, inflammatory responses, [21] or wound healing processes have to be taken into consideration for long-term sampling as they may influence the experimental outcome. From a practical perspective, it has been suggested to perform microdialysis experiments within an optimal time window, usually 24–48 hours after probe insertion. [35] [36]
  2. Microdialysis has a relatively low temporal and spatial resolution compared to, for example, electrochemical biosensors. While the temporal resolution is determined by the length of the sampling intervals (usually a few minutes), the spatial resolution is determined by the dimensions of the probe. The probe size can vary between different areas of application and covers a range of a few millimeters (intracerebral application) up to a few centimeters (subcutaneous application) in length and a few hundred micrometers in diameter.[ citation needed ]
  3. Application of the microdialysis technique is often limited by the determination of the probe’s recovery, especially for in vivo experiments. Determination of the recovery may be time-consuming and may require additional subjects or pilot experiments. The recovery is largely dependent on the flow rate: the lower the flow rate, the higher the recovery. However, in practice the flow rate cannot be decreased too much since either the sample volume obtained for analysis will be insufficient or the temporal resolution of the experiment will be lost. It is therefore important to optimize the relationship between flow rate and the sensitivity of the analytical assay. The situation may be more complex for lipophilic compounds as they can stick to the tubing or other probe components, resulting in a low or no analyte recovery.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Kidney dialysis</span> Removal of nitrogenous waste and toxins from the body in place of or to augment the kidney

Kidney dialysis is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally. This is referred to as renal replacement therapy. The first successful dialysis was performed in 1943.

In vitro toxicity testing is the scientific analysis of the toxic effects of chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.

<span class="mw-page-title-main">Dialysis (chemistry)</span> Process of separating molecules

In chemistry, dialysis is the process of separating molecules in solution by the difference in their rates of diffusion through a semipermeable membrane, such as dialysis tubing.

<span class="mw-page-title-main">Hemodialysis</span> Medical procedure for purifying blood

Hemodialysis, also spelled haemodialysis, or simply dialysis, is a process of purifying the blood of a person whose kidneys are not working normally. This type of dialysis achieves the extracorporeal removal of waste products such as creatinine and urea and free water from the blood when the kidneys are in a state of kidney failure. Hemodialysis is one of three renal replacement therapies. An alternative method for extracorporeal separation of blood components such as plasma or cells is apheresis.

<span class="mw-page-title-main">Perfusion</span> Passage of fluid through the circulatory or lymphatic system to an organ or tissue

Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion may also refer to fixation via perfusion, used in histological studies. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time per unit tissue mass. The SI unit is m3/(s·kg), although for human organs perfusion is typically reported in ml/min/g. The word is derived from the French verb "perfuser" meaning to "pour over or through". All animal tissues require an adequate blood supply for health and life. Poor perfusion (malperfusion), that is, ischemia, causes health problems, as seen in cardiovascular disease, including coronary artery disease, cerebrovascular disease, peripheral artery disease, and many other conditions.

Machine perfusion (MP) is a technique used in organ transplantation as a means of preserving the organs which are to be transplanted.

Distribution in pharmacology is a branch of pharmacokinetics which describes the reversible transfer of a drug from one location to another within the body.

In physics and engineering, permeation is the penetration of a permeate through a solid. It is directly related to the concentration gradient of the permeate, a material's intrinsic permeability, and the materials' mass diffusivity. Permeation is modeled by equations such as Fick's laws of diffusion, and can be measured using tools such as a minipermeameter.

Perfusion is the passage of fluid through the lymphatic system or blood vessels to an organ or a tissue. The practice of perfusion scanning is the process by which this perfusion can be observed, recorded and quantified. The term perfusion scanning encompasses a wide range of medical imaging modalities.

<span class="mw-page-title-main">Bio-MEMS</span>

Bio-MEMS is an abbreviation for biomedical microelectromechanical systems. Bio-MEMS have considerable overlap, and is sometimes considered synonymous, with lab-on-a-chip (LOC) and micro total analysis systems (μTAS). Bio-MEMS is typically more focused on mechanical parts and microfabrication technologies made suitable for biological applications. On the other hand, lab-on-a-chip is concerned with miniaturization and integration of laboratory processes and experiments into single chips. In this definition, lab-on-a-chip devices do not strictly have biological applications, although most do or are amenable to be adapted for biological purposes. Similarly, micro total analysis systems may not have biological applications in mind, and are usually dedicated to chemical analysis. A broad definition for bio-MEMS can be used to refer to the science and technology of operating at the microscale for biological and biomedical applications, which may or may not include any electronic or mechanical functions. The interdisciplinary nature of bio-MEMS combines material sciences, clinical sciences, medicine, surgery, electrical engineering, mechanical engineering, optical engineering, chemical engineering, and biomedical engineering. Some of its major applications include genomics, proteomics, molecular diagnostics, point-of-care diagnostics, tissue engineering, single cell analysis and implantable microdevices.

<span class="mw-page-title-main">Langendorff heart</span> Preparation technique for ex vivo experiments

The Langendorff heart or isolated perfused heart assay is an ex vivo technique used in pharmacological and physiological research using animals and also humans. Named after the German physiologist Oskar Langendorff, this technique allows the examination of cardiac contractile strength and heart rate without the complications of an intact animal or human. After more than 100 years, this method is still being used.

<span class="mw-page-title-main">Slice preparation</span> Laboratory method involving brain slices

The slice preparation or brain slice is a laboratory technique in electrophysiology that allows the study of neurons from various brain regions in isolation from the rest of the brain, in an ex-vivo condition. Brain tissue is initially sliced via a tissue slicer then immersed in artificial cerebrospinal fluid (aCSF) for stimulation and/or recording. The technique allows for greater experimental control, through elimination of the effects of the rest of the brain on the circuit of interest, careful control of the physiological conditions through perfusion of substrates through the incubation fluid, to precise manipulation of neurotransmitter activity through perfusion of agonists and antagonists. However, the increase in control comes with a decrease in the ease with which the results can be applied to the whole neural system.

An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture, integrated circuit (chip) that simulates the activities, mechanics and physiological response of an entire organ or an organ system. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context. By acting as a more sophisticated in vitro approximation of complex tissues than standard cell culture, they provide the potential as an alternative to animal models for drug development and toxin testing.

Push–pull perfusion is an in vivo sampling method most commonly used for measuring neurotransmitters in the brain. Developed by J.H. Gaddum in 1960, this technique replaced the cortical cup technique for observing neurotransmitters. The advent of concentric microdialysis probes in the 1980s resulted in push-pull sampling falling out of favor, as such probes require less monitoring, and are less invasive than the higher flow rate push-pull probes (>10 microliter/min), which could result in lesions if flow is unbalanced.

Ion suppression in LC-MS and LC-MS/MS refers to reduced detector response, or signal:noise as a manifested effect of competition for ionisation efficiency in the ionisation source, between the analyte(s) of interest and other endogenous or exogenous species which have not been removed from the sample matrix during sample preparation. Ion suppression is not strictly a problem unless interfering compounds elute at the same time as the analyte of interest. In cases where ion suppressing species do co-elute with an analyte, the effects on the important analytical parameters including precision, accuracy and limit of detection can be extensive, severely limiting the validity of an assay's results.

<span class="mw-page-title-main">Fast-scan cyclic voltammetry</span> Method of chemical analysis

Fast-scan cyclic voltammetry (FSCV) is cyclic voltammetry with a very high scan rate (up to 1×106 V·s−1). Application of high scan rate allows rapid acquisition of a voltammogram within several milliseconds and ensures high temporal resolution of this electroanalytical technique. An acquisition rate of 10 Hz is routinely employed.

A polar organic chemical integrative sampler (POCIS) is a passive sampling device which allows for the in situ collection of a time-integrated average of hydrophilic organic contaminants developed by researchers with the United States Geological Survey in Columbia, Missouri. POCIS provides a means for estimating the toxicological significance of waterborne contaminants. The POCIS sampler mimics the respiratory exposure of organisms living in the aquatic environment and can provide an understanding of bioavailable contaminants present in the system. POCIS can be deployed in a wide range of aquatic environments and is commonly used to assist in environmental monitoring studies.

<span class="mw-page-title-main">Passive sampling</span>

Passive sampling is an environmental monitoring technique involving the use of a collecting medium, such as a man-made device or biological organism, to accumulate chemical pollutants in the environment over time. This is in contrast to grab sampling, which involves taking a sample directly from the media of interest at one point in time. In passive sampling, average chemical concentrations are calculated over a device's deployment time, which avoids the need to visit a sampling site multiple times to collect multiple representative samples. Currently, passive samplers have been developed and deployed to detect toxic metals, pesticides, pharmaceuticals, radionuclides, polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and other organic compounds in water, while some passive samplers can detect hazardous substances in the air.

Probe electrospray ionization (PESI) is an electrospray-based ambient ionization technique which is coupled with mass spectrometry for sample analysis. Unlike traditional mass spectrometry ion sources which must be maintained in a vacuum, ambient ionization techniques permit sample ionization under ambient conditions, allowing for the high-throughput analysis of samples in their native state, often with minimal or no sample pre-treatment. The PESI ion source simply consists of a needle to which a high voltage is applied following sample pick-up, initiating electrospray directly from the solid needle.

Open flow microperfusion (OFM) is a sampling method for clinical and preclinical drug development studies and biomarker research. OFM is designed for continuous sampling of analytes from the interstitial fluid (ISF) of various tissues. It provides direct access to the ISF by insertion of a small, minimally invasive, membrane-free probe with macroscopic openings. Thus, the entire biochemical information of the ISF becomes accessible regardless of the analyte's molecular size, protein-binding property or lipophilicity.

References

  1. 1 2 3 4 5 6 7 Chaurasia CS, Müller M, Bashaw ED, Benfeldt E, Bolinder J, Bullock R, Bungay PM, DeLange EC, Derendorf H, Elmquist WF, Hammarlund-Udenaes M, Joukhadar C, Kellogg DL, Lunte CE, Nordstrom CH, Rollema H, Sawchuk RJ, Cheung BW, Shah VP, Stahle L, Ungerstedt U, Welty DF, Yeo H (May 2007). "AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives". Pharmaceutical Research. 24 (5): 1014–25. doi:10.1007/s11095-006-9206-z. PMID   17458685. S2CID   8087765.
  2. ↑ "Proceedings of the Physiological Society". The Journal of Physiology. 155: 1–28. 1961. doi:10.1113/jphysiol.1961.sp006651. S2CID   222200988.
  3. ↑ Bito L, Davson H, Levin E, Murray M, Snider N (November 1966). "The concentrations of free amino acids and other electrolytes in cerebrospinal fluid, in vivo dialysate of brain, and blood plasma of the dog". Journal of Neurochemistry. 13 (11): 1057–67. doi:10.1111/j.1471-4159.1966.tb04265.x. PMID   5924657. S2CID   32976369.
  4. 1 2 Delgado JM, DeFeudis FV, Roth RH, Ryugo DK, Mitruka BM (1972). "Dialytrode for long term intracerebral perfusion in awake monkeys". Archives Internationales de Pharmacodynamie et de Thérapie. 198 (1): 9–21. PMID   4626478.
  5. ↑ Ungerstedt U, Pycock C (July 1974). "Functional correlates of dopamine neurotransmission". Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften. 30 (1–3): 44–55. PMID   4371656.
  6. ↑ Li, Tuo; Yang, Hui; Li, Xing; Hou, Yinzhu; Zhao, Yao; Wu, Wenjing; Zhao, Lingyu; Wang, Fuyi; Zhao, Zhenwen (2021). "Open-flow microperfusion combined with mass spectrometry for in vivo liver lipidomic analysis". The Analyst. 146 (6): 1915–1923. Bibcode:2021Ana...146.1915L. doi:10.1039/D0AN02189J. ISSN   0003-2654. PMID   33481970. S2CID   231689183.
  7. ↑ Bodenlenz, Manfred; Höfferer, Christian; Magnes, Christoph; Schaller-Ammann, Roland; Schaupp, Lukas; Feichtner, Franz; Ratzer, Maria; Pickl, Karin; Sinner, Frank; Wutte, Andrea; Korsatko, Stefan (August 2012). "Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling". European Journal of Pharmaceutics and Biopharmaceutics. 81 (3): 635–641. doi:10.1016/j.ejpb.2012.04.009. PMID   22554768.
  8. ↑ Bodenlenz, Manfred; Höfferer, Christian; Magnes, Christoph; Schaller-Ammann, Roland; Schaupp, Lukas; Feichtner, Franz; Ratzer, Maria; Pickl, Karin; Sinner, Frank; Wutte, Andrea; Korsatko, Stefan (August 2012). "Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling". European Journal of Pharmaceutics and Biopharmaceutics. 81 (3): 635–641. doi:10.1016/j.ejpb.2012.04.009. ISSN   0939-6411. PMID   22554768.
  9. ↑ Altendorfer-Kroath, Thomas; Schimek, Denise; Eberl, Anita; Rauter, Günther; Ratzer, Maria; Raml, Reingard; Sinner, Frank; Birngruber, Thomas (January 2019). "Comparison of cerebral Open Flow Microperfusion and Microdialysis when sampling small lipophilic and small hydrophilic substances". Journal of Neuroscience Methods. 311: 394–401. doi:10.1016/j.jneumeth.2018.09.024. ISSN   0165-0270. PMID   30266621. S2CID   52883354.
  10. ↑ Schaupp, L.; Ellmerer, M.; Brunner, G. A.; Wutte, A.; Sendlhofer, G.; Trajanoski, Z.; Skrabal, F.; Pieber, T. R.; Wach, P. (1999-02-01). "Direct access to interstitial fluid in adipose tissue in humans by use of open-flow microperfusion". American Journal of Physiology. Endocrinology and Metabolism. 276 (2): E401–E408. doi:10.1152/ajpendo.1999.276.2.e401. ISSN   0193-1849. PMID   9950802.
  11. ↑ Ellmerer, Martin; Schaupp, Lukas; Brunner, Gernot A.; Sendlhofer, Gerald; Wutte, Andrea; Wach, Paul; Pieber, Thomas R. (2000-02-01). "Measurement of interstitial albumin in human skeletal muscle and adipose tissue by open-flow microperfusion". American Journal of Physiology. Endocrinology and Metabolism. 278 (2): E352–E356. doi:10.1152/ajpendo.2000.278.2.e352. ISSN   0193-1849. PMID   10662720. S2CID   11616153.
  12. ↑ Dragatin, Christian; Polus, Florine; Bodenlenz, Manfred; Calonder, Claudio; Aigner, Birgit; Tiffner, Katrin Irene; Mader, Julia Katharina; Ratzer, Maria; Woessner, Ralph; Pieber, Thomas Rudolf; Cheng, Yi (2015-11-23). "Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion". Experimental Dermatology. 25 (2): 157–159. doi: 10.1111/exd.12863 . ISSN   0906-6705. PMID   26439798.
  13. ↑ Kolbinger, Frank; Loesche, Christian; Valentin, Marie-Anne; Jiang, Xiaoyu; Cheng, Yi; Jarvis, Philip; Peters, Thomas; Calonder, Claudio; Bruin, Gerard; Polus, Florine; Aigner, Birgit (March 2017). "β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis". Journal of Allergy and Clinical Immunology. 139 (3): 923–932.e8. doi: 10.1016/j.jaci.2016.06.038 . ISSN   0091-6749. PMID   27502297.
  14. ↑ Kleinert, Maximilian; Kotzbeck, Petra; Altendorfer-Kroath, Thomas; Birngruber, Thomas; Tschöp, Matthias H.; Clemmensen, Christoffer (December 2019). "Corrigendum to "Time-resolved hypothalamic open flow micro-perfusion reveals normal leptin transport across the blood–brain barrier in leptin resistant mice" [Molecular Metabolism 13 (2018) 77–82]". Molecular Metabolism. 30: 265. doi:10.1016/j.molmet.2019.11.001. ISSN   2212-8778. PMC   6889745 . PMID   31767178.
  15. 1 2 3 Stahl M, Bouw R, Jackson A, Pay V (June 2002). "Human microdialysis". Current Pharmaceutical Biotechnology. 3 (2): 165–78. doi:10.2174/1389201023378373. PMID   12022259.
  16. ↑ Bouw, M. René; Hammarlund‐Udenaes, Margareta (1998). "Methodological aspects of the use of a calibrator in in vivo microdialysis-further development of the retrodialysis method". Pharmaceutical Research. 15 (11): 1673–1679. doi:10.1023/A:1011992125204. PMID   9833986. S2CID   11177946.
  17. 1 2 Lönnroth P, Jansson PA, Smith U (August 1987). "A microdialysis method allowing characterization of intercellular water space in humans". The American Journal of Physiology. 253 (2 Pt 1): E228-31. doi:10.1152/ajpendo.1987.253.2.E228. PMID   3618773. S2CID   5766876.
  18. 1 2 3 4 Olson RJ, Justice JB (2002). "Quantitative microdialysis under transient conditions". Analytical Chemistry. 65 (8): 1017–1022. doi:10.1021/ac00056a012. PMID   8494171.
  19. 1 2 Wang Y, Wong SL, Sawchuk RJ (October 1993). "Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus". Pharmaceutical Research. 10 (10): 1411–9. doi:10.1023/A:1018906821725. PMID   8272401. S2CID   20232288.
  20. ↑ Benveniste H, Hüttemeier PC (1990). "Microdialysis--theory and application". Progress in Neurobiology. 35 (3): 195–215. doi:10.1016/0301-0082(90)90027-E. PMID   2236577. S2CID   29998649.
  21. 1 2 Carson BP, McCormack WG, Conway C, Cooke J, Saunders J, O'Connor WT, Jakeman PM (February 2015). "An in vivo microdialysis characterization of the transient changes in the interstitial dialysate concentration of metabolites and cytokines in human skeletal muscle in response to insertion of a microdialysis probe". Cytokine. 71 (2): 327–33. doi:10.1016/j.cyto.2014.10.022. PMID   25528289.
  22. ↑ Yoshikawa, M., Kawaguchi, M. (April 2021). "In Vivo Monitoring of Acetylcholine Release from Nerve Endings in Salivary Gland". Biology. 10 (5): 351. doi: 10.3390/biology10050351 . PMC   8143079 . PMID   33919193.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  23. ↑ Mindermann T, Zimmerli W, Gratzl O (October 1998). "Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space". Antimicrobial Agents and Chemotherapy. 42 (10): 2626–9. doi:10.1128/aac.42.10.2626. PMC   105908 . PMID   9756766.
  24. ↑ Müller M, dela Peña A, Derendorf H (May 2004). "Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue". Antimicrobial Agents and Chemotherapy. 48 (5): 1441–53. doi:10.1128/aac.48.5.1441-1453.2004. PMC   400530 . PMID   15105091.
  25. ↑ Chefer VI, Thompson AC, Zapata A, Shippenberg TS (April 2009). "Overview of brain microdialysis". Current Protocols in Neuroscience. Chapter 7: 7.1.1–7.1.28. doi:10.1002/0471142301.ns0701s47. PMC   2953244 . PMID   19340812.
  26. ↑ Schmidt S, Banks R, Kumar V, Rand KH, Derendorf H (March 2008). "Clinical microdialysis in skin and soft tissues: an update". Journal of Clinical Pharmacology. 48 (3): 351–64. doi:10.1177/0091270007312152. PMID   18285620. S2CID   12379638.
  27. ↑ Miro M, Frenzel W (2005). "The potential of microdialysis as an automatic sample-processing technique for environmental research". TrAC Trends in Analytical Chemistry. 24 (4): 324–333. doi:10.1016/j.trac.2004.10.004.
  28. ↑ Torto N, Lobelo B, Gorton L (2000). "Determination of saccharides in wastewater from the beverage industry by microdialysis sampling, microbore high performance anion exchange chromatography and integrated pulsed electrochemical detection". The Analyst. 125 (8): 1379–1381. Bibcode:2000Ana...125.1379T. doi:10.1039/b004064i.
  29. ↑ Torto N, Mwatseteza J, Sawula G (2002). "A study of microdialysis sampling of metal ions". Analytica Chimica Acta. 456 (2): 253–261. doi:10.1016/S0003-2670(02)00048-X.
  30. ↑ Humphrey, O. S., Young, S. D., Crout, N. M., Bailey, E. H., Ander, E. L., & Watts, M. J. (2020). Short-term iodine dynamics in soil solution. Environmental science & technology, 54(3), 1443-1450.
  31. ↑ Sulyok M, Miró M, Stingeder G, Koellensperger G (August 2005). "The potential of flow-through microdialysis for probing low-molecular weight organic anions in rhizosphere soil solution". Analytica Chimica Acta. 546 (1): 1–10. doi:10.1016/j.aca.2005.05.027. PMID   29569545.
  32. ↑ Inselsbacher, Erich; Öhlund, Jonas; Jämtgård, Sandra; Huss-Danell, Kerstin; Näsholm, Torgny (2011). "The potential of microdialysis to monitor organic and inorganic nitrogen compounds in soil". Soil Biology and Biochemistry. 43 (6): 1321–1332. doi:10.1016/j.soilbio.2011.03.003.
  33. ↑ Inselsbacher, Erich (2014). "Recovery of individual soil nitrogen forms after sieving and extraction". Soil Biology and Biochemistry. 71: 76–86. doi:10.1016/j.soilbio.2014.01.009.
  34. ↑ Morgan ME, Singhal D, Anderson BD (May 1996). "Quantitative assessment of blood-brain barrier damage during microdialysis". The Journal of Pharmacology and Experimental Therapeutics. 277 (2): 1167–76. PMID   8627529.
  35. ↑ Di Chiara G, Tanda G, Carboni E (November 1996). "Estimation of in-vivo neurotransmitter release by brain microdialysis: the issue of validity". Behavioural Pharmacology. 7 (7): 640–657. doi:10.1097/00008877-199611000-00009. PMID   11224460.
  36. ↑ Damsma G, Westerink BH, Imperato A, Rollema H, de Vries JB, Horn AS (August 1987). "Automated brain dialysis of acetylcholine in freely moving rats: detection of basal acetylcholine". Life Sciences. 41 (7): 873–6. doi:10.1016/0024-3205(87)90695-3. PMID   3613848.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.